Literature DB >> 18581348

Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.

Hassan Abdel-Aty1, Myra Cocker, Oliver Strohm, Neil Filipchuk, Matthias G Friedrich.   

Abstract

PURPOSE: To explore if focal T2 abnormalities accompany late gadolinium enhancement (LGE) lesions in hypertrophic cardiomyopathy (HCM).
MATERIALS AND METHODS: All studies were performed under the guidelines of the local ethics committee, which approved the study, and a written informed consent was obtained from each subject. We studied 27 patients (24 males, 51 +/- 18 years) with HCM and evidence for myocardial injury as defined by LGE. The following sequences were performed: steady-state free precession (SSFP) (ventricular volumes, mass, and function), T2-weighted triple inversion-recovery spin-echo and inversion-recovery gradient-echo 10 minutes after intravenous (IV) gadolinium-DTPA (late enhancement).
RESULTS: Focal high T2 signal intensity (SI) frequently matching areas of LGE was observed in nine patients (33%). The presence of these abnormalities correlated with more severe left ventricular hypertrophy (1.5 +/- 0.6 vs. 1.0 +/- 0.4 g/cm; P < 0.05).
CONCLUSION: In this observational study, we identified focal T2 abnormalities in a subgroup of HCM patients. T2 abnormalities are associated with severe left ventricular hypertrophy. This may provide new insights into the mechanisms of focal irreversible injury in HCM and help in managing these patients. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581348     DOI: 10.1002/jmri.21381

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  25 in total

Review 1.  Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease.

Authors:  M Francone; I Carbone; L Agati; C Bucciarelli Ducci; M Mangia; I Iacucci; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

Review 2.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

Review 3.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

4.  Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.

Authors:  Anthony H Aletras; Gauri S Tilak; Li-Yueh Hsu; Andrew E Arai
Journal:  Circ Cardiovasc Imaging       Date:  2011-05-16       Impact factor: 7.792

5.  T2-weighted imaging to assess post-infarct myocardium at risk.

Authors:  Matthias G Friedrich; Han W Kim; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

Review 6.  Myocardial edema imaging by cardiovascular magnetic resonance: current status and future potential.

Authors:  Iacopo Carbone; Matthias G Friedrich
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

7.  Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction.

Authors:  Jens Vogel-Claussen; Miguel Santaularia Tomas; Amit Newatia; Danielle Boyce; Aurelio Pinheiro; Roselle Abraham; Theodore Abraham; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2012-05-01       Impact factor: 4.813

8.  High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Yasuki Hen; Nobuo Iguchi; Haruhiko Machida; Kaori Takada; Yuko Utanohara; Tetsuya Sumiyoshi
Journal:  Heart Vessels       Date:  2012-10-25       Impact factor: 2.037

Review 9.  Cardiovascular magnetic resonance of cardiomyopathies.

Authors:  Francisco Alpendurada; Rory O'Hanlon; Sanjay K Prasad
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

10.  T2-weighted and delayed enhancement MRI of eosinophilic myocarditis: relationship with clinical phases and global cardiac function.

Authors:  Hitomi Tani; Yasuo Amano; Masaki Tachi; Tadashi Machida; Kyoichi Mizuno; Shinichiro Kumita
Journal:  Jpn J Radiol       Date:  2012-09-07       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.